Gene · 4048
Papers1,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms and biomarkers of successful allergen-specific immunotherapy. | Asia Pac Allergy | 2022 | 36452016 | PubTator, text mining | PubMed |
| Computation and molecular pharmacology to trace the anti-rheumatoid activity of Angelicae Pubescentis Radix. | BMC Complement Med Ther | 2022 | 36435778 | PubTator, text mining | PubMed |
| Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update. | Allergy Asthma Immunol Res | 2022 | 36426395 | PubTator, text mining | PubMed |
| Host-Directed Therapies for Tuberculosis. | Pathogens | 2022 | 36365041 | PubTator, text mining | PubMed |
| Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation. | Microorganisms | 2022 | 36363728 | PubTator, text mining | PubMed |
| Urinary Cysteinyl Leukotrienes as Biomarkers of Endothelial Activation, Inflammation and Oxidative Stress and Their Relationship with Organ Dysfunction in Human Septic Shock. | Biomedicines | 2022 | 36359365 | PubTator, text mining | PubMed |
| Critical Role of Inflammation and Specialized Pro-Resolving Mediators in the Pathogenesis of Atherosclerosis. | Biomedicines | 2022 | 36359349 | PubTator, text mining | PubMed |
| Cortex Mori extracts induce apoptosis and inhibit tumor invasion via blockage of the PI3K/AKT signaling in melanoma cells. | Front Pharmacol | 2022 | 36339598 | PubTator, text mining | PubMed |
| Blockade of the BLT1-LTB4 axis does not affect mast cell migration towards advanced atherosclerotic lesions in LDLr-/- mice. | Sci Rep | 2022 | 36319730 | PubTator, text mining | PubMed |
| Network pharmacology and molecular docking analysis on the mechanism of Baihe Zhimu decoction in the treatment of postpartum depression. | Medicine (Baltimore) | 2022 | 36316904 | PubTator, text mining | PubMed |
| Blockade of Platelet CysLT1R Receptor with Zafirlukast Counteracts Platelet Protumoral Action and Prevents Breast Cancer Metastasis to Bone and Lung. | Int J Mol Sci | 2022 | 36293074 | PubTator, text mining | PubMed |
| Transcellular biosynthesis of leukotriene B4 orchestrates neutrophil swarming to fungi. | iScience | 2022 | 36267914 | PubTator, text mining | PubMed |
| Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor. | Medicine (Baltimore) | 2022 | 36254028 | PubTator, text mining | PubMed |
| Biobehavioral factors predict an exosome biomarker of ovarian carcinoma disease progression. | Cancer | 2022 | 36251340 | PubTator, text mining | PubMed |
| Network Pharmacology-Based Analysis of the Potential Biological Mechanisms of Coix Seed against Colorectal Cancer. | Evid Based Complement Alternat Med | 2022 | 36248436 | PubTator, text mining | PubMed |
| N-3 polyunsaturated fatty acids may affect the course of COVID-19. | Front Immunol | 2022 | 36238306 | PubTator, text mining | PubMed |
| Human Pharmacokinetics of LYS006, an Oral Leukotriene A4 Hydrolase Inhibitor Displaying Target-Mediated Drug Disposition. | Drug Metab Dispos | 2022 | 36195338 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| Chronic air pollution-induced subclinical airway inflammation and polygenic susceptibility. | Respir Res | 2022 | 36151579 | PubTator, text mining | PubMed |
| Montelukast induces beneficial behavioral outcomes and reduces inflammation in male and female rats. | Front Immunol | 2022 | 36148246 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4048/papers?page=10